Tarsus Pharmaceuticals, Inc. TARS Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s change in other assets?
- Tarsus Pharmaceuticals, Inc. (TARS) reported change in other assets of -$141K in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s change in other assets decreased by 12.8% year-over-year, from -$125K to -$141K.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s change in other assets?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s change in other assets has grown at a 34.8% compound annual growth rate (CAGR), from $215K to $527K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.